Stocks

Medicare limits coverage of Biogen's $28,000-a-year Alzheimer's drug

Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned, a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices.

COVID-19 vaccines give Walgreens an edge

Walgreens administered 15.6 million COVID-19 vaccinations and 6.5 million tests in the first quarter. It has also administered over 9 million booster doses to date.